Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

NCT01931865 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01931865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01931865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2012
Completion date
July 31, 2015
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain